Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
Drug Name: Pexelizumab [USAN:INN:BAN]
Description: A 25 kDa recombinant, humanized, single-chain antibody that binds to human C5 with a very high affinity & thereby blocks C5 cleavage by C5 convertases; for treatment of patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Nov 2017